Marine Sponge Xestospongia sp.: A Promising Source for Tuberculosis Drug Development - Computational Insights into Mycobactin Biosynthesis Inhibition

Authors

DOI:

https://doi.org/10.33084/bjop.v7i1.5513

Keywords:

Docking, Molecular dynamics, Mycobacterium tuberculosis, Mycobactin, Salicylate synthase, Xestospongia sp.

Abstract

Mycobacterium tuberculosis (MTB) remains the leading cause of infection, with a significant fatality rate, owing primarily to drug resistance. MTB contains the enzyme salicylate synthase, which regulates mycobactin production to bind iron ions from the host cell, facilitating the bacteria to grow and reproduce. This study investigates the potential of marine sponges to inhibit the MTB salicylate synthase by exploiting a computational approach combining molecular docking and dynamics simulations. Forty-six compounds from Xestospongia sp. were chosen from the Marine Natural Products database. The docking results selected four compounds (CMNPD15071, CMNPD7640, CMNPD26706, and CMNPD7639) from this sponge, which provide more negative binding energy than their inhibitors (RVE). After reclassifying their interactions, such as hydrophobic and hydrogen bonds, CMNPD15071 (Sulfuric acid mono-(8-methoxy-12b-methyl-6-oxo-2,3,6,12b-tetrahydro-1H-5-oxa-benzo[k]acephenanthrylen-11-yl) ester) and CMNPD7640 (secoadociaquinone B) performed molecular dynamics simulations to assess their stability. These two compounds show a promising stability profile compared to RVE based on RMSD, RMSF, SASA, and gyration analysis. Furthermore, the binding affinity prediction of these two compounds using the MM/GBSA calculation method reveals that CMNPD15071 (-38.48 kJ/mol) had the highest affinity for binding to MTB salicylate synthase compared to RVE (-35.36 kJ/mol) and CMNPD7640 (-26.03 kJ/mol). These findings demonstrate that compounds from Xestospongia sp. can block MTB mycobactin biosynthesis by inhibiting salicylate synthase.

Views: 717Downloads: 578

Downloads

Download data is not yet available.

Author Biographies

References

Pavlik I, Ulmann V, Hubelova D, Weston RT. Nontuberculous Mycobacteria as Sapronoses: A Review. Microorganisms. 2022;(10):1345–57. DOI: 10.3390/microorganisms10071345; PMCID: PMC9315685; PMID: 35889064

Delghandi MR, El-Matbouli M, Menanteau-Ledouble S. Mycobacteriosis and Infections with Non-tuberculous Mycobacteria in Aquatic Organisms: A Review. Microorganisms. 2020;(8):1368–86. DOI: 10.3390/microorganisms8091368; PMCID: PMC7564596; PMID: 32906655

Chandra P, Grigsby SJ, Philips JA. Immune evasion and provocation by Mycobacterium tuberculosis. Nat Rev Microbiol. 2022;20(12):750–66. DOI: 10.1038/s41579-022-00763-4; PMCID: PMC9310001;PMID: 35879556

Pai M, Behr MA, Dowdy D, Dheda K, Divangahi M, Boehme CC, Ginsberg A, et al. Tuberculosis. Nat Rev Dis Prim. 2016;2:16076. DOI: 10.1038/nrdp.2016.76; PMID: 27784885

Avoi R, Liaw YC. Tuberculosis Death Epidemiology and Its Associated Risk Factors in Sabah, Malaysia. Int J of Envir Res and Pub. 2021;18(18):9740. DOI: 10.3390/ijerph18189740; PMCID: PMC8470141; PMID: 34574665

Seung KJ, Keshavjee S, Rich ML. Multidrug-Resistant Tuberculosis and Extensively Drug-Resistant Tuberculosis. Cold Spring Harb Perspect Med. 2015;5(9):a017863. DOI: 10.1101/cshperspect.a017863; PMCID: PMC4561400; PMID: 25918181

Miethke M, Pieroni M, Weber T, Brönstrup M, Hammann P, Halby L, et al. Towards the sustainable discovery and development of new antibiotics. Nat Rev Chem. 2021;5(10):726–49. DOI: 10.1038/s41570-021-00313-1; PMCID: PMC8374425; PMID: 34426795

Mori M, Stelitano G, Griego A, Chiarelli LR, Cazzaniga G, Gelain A, et al. Synthesis and Assessment of the In Vitro and Ex Vivo Activity of Salicylate Synthase (Mbti) Inhibitors as New Candidates for the Treatment of Mycobacterial Infections. Pharmaceuticals. 2022;15(8):992–1012. DOI: 10.3390/ph15080992; PMCID: PMC9413995; PMID: 36015139

Liu Z, Liu F, Aldrich CC. Stereocontrolled Synthesis of a Potential Transition-State Inhibitor of the Salicylate Synthase MbtI from Mycobacterium tuberculosis. J Org Chem. 2015;80(13):6545–52. DOI: 10.1021/acs.joc.5b00455; PMCID: PMC4667787; PMID: 26035083

Zhang L, Hendrickson RC, Meikle V, Lefkowitz EJ, Ioerger TR, Niederweis M. Comprehensive analysis of iron utilization by Mycobacterium tuberculosis. PLOS Pathog. 2020;16(2):e1008337. DOI: 10.1371/journal.ppat.1008337; PMCID: PMC7058343; PMID: 32069330

Cloete R, Oppon E, Murungi E, Schubert WD, Christoffels A. Resistance related metabolic pathways for drug target identification in Mycobacterium tuberculosis. BMC Bioinformatics. 2016;17:75. DOI: 10.1186/s12859-016-0898-8; PMCID: PMC4745158; PMID: 26856535

Chiarelli LR, Mori M, Barlocco D, Beretta G, Gelain A, Pini E, et al. Discovery and development of novel salicylate synthase (MbtI) furanic inhibitors as antitubercular agents. Eur J Med Chem. 2018;155:754–63. DOI: 10.1016/j.ejmech.2018.06.033; PMID: 29940465

Chiarelli LR, Mori M, Beretta G, Gelain A, Pini E, Sammartino JC, et al. New insight into structure-activity of furan-based salicylate synthase (MbtI) inhibitors as potential antitubercular agents. J Enzyme Inhib Med Chem. 2019;34(1):823–8. DOI: 10.1080/14756366.2019.1589462; PMCID: PMC6427685; PMID: 30889995

Pini E, Poli G, Tuccinardi T, Chiarelli LR, Mori M, Gelain A, et al. New Chromane-Based Derivatives as Inhibitors of Mycobacterium tuberculosis Salicylate Synthase (MbtI): Preliminary Biological Evaluation and Molecular Modeling Studies. Molecules. 2018;23(7):1506. DOI: 10.3390/molecules23071506; PMCID: PMC6099841; PMID: 29933627

Karthikeyan A, Joseph A, Nair BG. Promising bioactive compounds from the marine environment and their potential effects on various diseases. J Genet Eng Biotechnol. 2022;20(1):14. DOI: 10.1186/s43141-021-00290-4; PMCID: PMC8790952; PMID: 35080679

Pujiastuti DY, Amin MNG, Alamsjah MA, Hsu JL. Marine Organisms as Potential Sources of Bioactive Peptides that Inhibit the Activity of Angiotensin I-Converting Enzyme: A Review. Molecules. 2019;(24):2541. DOI: 10.3390/molecules24142541; PMCID: PMC6680877; PMID: 31336853

Yamazaki H. Exploration of marine natural resources in Indonesia and development of efficient strategies for the production of microbial halogenated metabolites. J Nat Med. 2022;76(1):1–19. DOI: 10.1007/s11418-021-01557-3; PMCID: PMC8732978; PMID: 34415546

Swantara MD, Rita WS, Suartha N, Agustina KK. Anticancer activities of toxic isolate of Xestospongia testudinaria sponge. Vet World. 2019;12(9):1434–40. DOI: 10.14202/vetworld.2019.1434-1440; PMCID: PMC6813599; PMID: 31749578

Chi G, Manos-Turvey A, O’Connor PD, Johnston JM, Evans GL, Baker EN, et al. Implications of Binding Mode and Active Site Flexibility for Inhibitor Potency against the Salicylate Synthase from Mycobacterium tuberculosis. Biochemistry. 2012;51(24):4868–79. DOI: 10.1021/bi3002067; PMID: 22607697

Arba M, Arfan, Trisnawati A, Kurniawati D. Pemodelan Farmakofor untuk Identifikasi Inhibitor Heat Shock Proteins-90 (HSP-90). J Farmasi Galenika Galenika J Pharm. 2020;6(2):229–36. DOI: 10.22487/j24428744.2020.v6.i2.15036

Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, et al. AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility. J Comput Chem. 2009;30(16):2785-91. DOI: 10.1002/jcc.21256; PMCID: PMC2760638; PMID: 19399780

Lyu C, Chen T, Qiang B, Liu N, Wang H, Zhang L, Liu Z. CMNPD: a comprehensive marine natural products database towards facilitating drug discovery from the ocean. Nucleic Acids Res. 2021;49(D1):D509–15. DOI: 10.1093/nar/gkaa763; PMCID: PMC7779072; PMID: 32986829

O’Boyle NM, Banck M, James CA, Morley C, Vandermeersch T, Hutchison GR. Open Babel: An open chemical toolbox. J Cheminform. 2011;3:33. DOI: 10.1186/1758-2946-3-33; PMCID: PMC3198950; PMID: 21982300

Morris GM, Huey R, Olson AJ. Using AutoDock for ligand-receptor docking. Curr Protoc Bioinformatics. 2008;Ch8:Unit 8.14 DOI: 10.1002/0471250953.bi0814s24; PMID: 19085980

Arfan A, Muliadi R, Malina R, Trinovitasari N, Asnawi A. Docking and Dynamics Studies: Identifying the Binding Ability of Quercetin Analogs to the ADP-Ribose Phosphatase of SARS CoV-2. J Kartika Kimia. 2022;5(2):145–51. DOI: 10.26874/jkk.v5i2.143

Kohnke B, Kutzner C, Grubmüller H. A GPU-Accelerated Fast Multipole Method for GROMACS: Performance and Accuracy. J Chem Theory Comput. 2020;16(11):6938–49. DOI: 10.1021/acs.jctc.0c00744; PMCID: PMC7660746; PMID: 33084336

Petrov D, Zagrovic B. Are current atomistic force fields accurate enough to study proteins in crowded environments? PLoS Comput Biol. 2014;10(5):e1003638. DOI: 10.1371/journal.pcbi.1003638; PMCID: PMC4031056; PMID: 24854339

Wang J, Wolf RM, Caldwell JW, Kollman PA, Case DA. Development and testing of a general amber force field. J Comput Chem. 2004;25(9):1157–74. DOI: 10.1002/jcc.20035; PMID: 15116359

da Silva AWS, Vranken WF. ACPYPE - AnteChamber PYthon Parser interfacE. BMC Res Notes. 2012;5(367):367. DOI: 10.1186/1756-0500-5-367; PMCID: PMC3461484; PMID: 22824207

Asnawi A, Febrina E, Aligita W, Yuliantini A, Arfan A. Penambatan Molekul dan Dinamika Molekul beberapa Fitokimia dari Acalypha Indica L. sebagai Inhibitor Matriks Metalloproteinase9. J Sains Farmasi Klinis. 2023;10(1):69–77. DOI: 10.25077/jsfk.10.1.69-77.2023

Aman LO, Sihaloho M, Arfan A. Pencarian Inhibitor DYRK2 dari Database Bahan Alam Zinc15: Analisis Farmakofor, Simulasi Docking dan Dinamika Molekuler. J Sains Farmasi Klinis. 2023;10(1):100–13. DOI: 10.25077/jsfk.10.1.100-113.2023

Asnawi A, Aman LO, Yuliantini A, Febrina E. Molecular Docking and Molecular Dynamic Studies: Screening Phytochemicals of Acalypha Indica against Braf Kinase Receptors for Potential use in Melanocytic Tumours. Rasāyan J Chem. 2022;15(2):1352–61. DOI: 10.31788/RJC.2022.1526769

Meng XY, Zhang HX, Mezei M, Cui M. Molecular docking: a powerful approach for structure-based drug discovery. Curr Comput Aided Drug Des. 2011;7(2):146-57. DOI: 10.2174/157340911795677602; PMCID: PMC3151162; PMID: 21534921

Rampogu S, Lee G, Park JS, Lee KW, Kim MO. Molecular Docking and Molecular Dynamics Simulations Discover Curcumin Analogue as a Plausible Dual Inhibitor for SARS-CoV-2. Int J Mol Sci. 2022;23(3):1771. DOI: 10.3390/ijms23031771; PMCID: PMC8836015; PMID: 35163692

Citra SNAL, Arfan A, Alroem A, Bande LS, Irnawati I, Arba M. Docking-based workflow and ADME prediction of some compounds in Curcuma longa and Andrographis paniculata as polymerase PA-PB1 inhibitors of influenza A/H5N1 virus. J Res Pharm. 2023;27(1):221–31. DOI: 10.29228/jrp.305

Du X, Li Y, Xia YL, Ai SM, Liang J, Sang P, et al. Insights into Protein-Ligand Interactions: Mechanisms, Models, and Methods. Int J Mol Sci. 2016;17(2):144. DOI: 10.3390/ijms17020144; PMCID: PMC4783878; PMID: 26821017

Ghahremanian S, Rashidi MM, Raeisi K, Toghraie D. Molecular dynamics simulation approach for discovering potential inhibitors against SARS-CoV-2: A structural review. J Mol Liq. 2022;354:118901. DOI: 10.1016/j.molliq.2022.118901; PMCID: PMC8916543; PMID: 35309259

Rakhsit G, Biswas A, Jayaprakash V. In Silico Drug Repurposing Studies for the Discovery of Novel Salicyl-AMP Ligase (MbtA)Inhibitors. Pathogens. 2023;12(12):1433. DOI: 10.3390/pathogens12121433; PMCID: PMC10745912; PMID: 38133316

Ali SA, Hassan MI, Islam A, Ahmad F. A review of methods available to estimate solvent-accessible surface areas of soluble proteins in the folded and unfolded states. Curr Protein Pept Sci. 2014;15(5):456-76. DOI: 10.2174/1389203715666140327114232; PMID: 24678666

Genheden S, Ryde U. The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities. Expert Opin Drug Discov. 2015;10(5):449-61. DOI: 10.1517/17460441.2015.1032936; PMCID: PMC4487606; PMID: 25835573

Li Z, Chan KC, Nickels JD, Cheng X. Electrostatic Contributions to the Binding Free Energy of Nicotine to the Acetylcholine Binding Protein. J Phys Chem B. 2022;126(43):8669-79. DOI: 10.1021/acs.jpcb.2c04641; PMCID: PMC10056799; PMID: 36260486

Arfan A, Muliadi R, Rayani R. Eksplorasi Senyawa Penghambat Enzim Salisilat Sintase dari Mycobacterium tuberculosis melalui Studi Penambatan Molekul dan Prediksi Sifat ADME. Lansau J Ilmu Kefarmasian. 2023;1(1):77-88. DOI: 10.33772/lansau.v1i1.9

Izadi S, Aguilar B, Onufriev AV. Protein-Ligand Electrostatic Binding Free Energies from Explicit and Implicit Solvation. J Chem Theory Comput. 2015;11(9):4450-9. DOI: 10.1021/acs.jctc.5b00483; PMCID: PMC5217485; PMID: 26575935

Pantsar T, Poso A. Binding Affinity via Docking: Fact and Fiction. Molecules. 2018;23(8):1899. DOI: 10.3390/molecules23081899; PMCID: PMC6222344; PMID: 30061498

Roth CM, Neal BL, Lenhoff AM. Van der Waals interactions involving proteins. Biophys J. 1996;70(2):977-87. DOI: 10.1016/s0006-3495(96)79641-8; PMCID: PMC1224998; PMID: 8789115

Downloads

Published

02/29/2024

Issue

Section

Analytical Pharmacy-Medicinal Chemistry

Categories

How to Cite

1.
Arfan A, Asnawi A, Aman LO. Marine Sponge Xestospongia sp.: A Promising Source for Tuberculosis Drug Development - Computational Insights into Mycobactin Biosynthesis Inhibition. Borneo J Pharm [Internet]. 2024 Feb. 29 [cited 2026 Nov. 18];7(1):40-5. Available from: https://journal.umpr.ac.id/index.php/bjop/article/view/5513

Similar Articles

111-120 of 135

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)